- Feb 5, 2002
- 166,485
- 56,168
- Country
- United States
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Others
The Food and Drug Administration is expected to announce new standards for approving a coronavirusvaccine in an apparent attempt to shore up confidence with the American people, according to a report.
The Washington Post reported on Tuesday that two individuals familiar with the issue said the FDA will ask manufacturers to follow clinical trial participants for at least two months in order to obtain an emergency authorization.
Additionally, trials will have to show evidence surrounding more severe cases and older people, making it unlikely that a vaccine will be finished before the 2020 presidential election. Moderna and Pfizer each started their trials in July. The enrollment process took about a month with a second round of shots being administered after three or four weeks in the trial.
The White House has indicated a vaccine could be approved by November. President Trump told "Fox & Friends" earlier this month that an approval could come within "a matter of weeks." He also indicated during a press conference that distribution could begin in October.
Continued below.
FDA set to announce greater restrictions for COVID-19 vaccine: Report
The Washington Post reported on Tuesday that two individuals familiar with the issue said the FDA will ask manufacturers to follow clinical trial participants for at least two months in order to obtain an emergency authorization.
Additionally, trials will have to show evidence surrounding more severe cases and older people, making it unlikely that a vaccine will be finished before the 2020 presidential election. Moderna and Pfizer each started their trials in July. The enrollment process took about a month with a second round of shots being administered after three or four weeks in the trial.
The White House has indicated a vaccine could be approved by November. President Trump told "Fox & Friends" earlier this month that an approval could come within "a matter of weeks." He also indicated during a press conference that distribution could begin in October.
Continued below.
FDA set to announce greater restrictions for COVID-19 vaccine: Report
